Research Article
Health-Related Quality of Life in the Gender, Race, And Clinical Experience Trial
Table 2
Results from the univariate analysis to investigate factors associated with improvements in total FAHI score over 48 weeks.
| | Covariate | P value |
| | Baseline FAHI | <.0001 | | Baseline CD4+ count | .0052 | | Confirmed virologic response | .0335 | | History of psychological illness | .0570 | | Baseline log10 viral load | .0862 | | Stage of HIV infection | .1441 | | Sex | .1979 | | Presence of etravirine in the OBR | .2062 | | Alcohol use | .2700 | | Duration of diagnosis | .2995 | | Black race versus other | .3490 | | Incidence of grade 2–4 AE | .4374 | | Smoker | .5272 | | Presence of hepatitis C antibody | .5938 | | Age | .7183 | | Structured treatment interruption | .7757 | | Adherence | .8049 | | Drug use | .9548 |
|
|
FAHI: Functional Assessment of HIV Infection; OBR: optimized background regimen; AE: adverse event.
|